No Racial Difference in Prognostic Value of Cardiorespiratory Fitness

This article originally appeared here.
Share this content:
No Racial Difference in Prognostic Value of Cardiorespiratory Fitness
No Racial Difference in Prognostic Value of Cardiorespiratory Fitness

FRIDAY, April 15, 2016 (HealthDay News) -- Cardiorespiratory fitness (CRF) predicts all-cause mortality, with no racial differences in its prognostic value, according to a study published in the May 1 issue of The American Journal of Cardiology.

Mouaz H. Al-Mallah, M.D., from the Henry Ford Hospital in Detroit, and colleagues analyzed data from 53,876 patients from the Henry Ford Exercise Testing project without established coronary disease or heart failure who completed a maximal exercise test from 1991 to 2009. Participants were followed for a mean of 11.5 years for all-cause mortality and for a mean of 6.2 years for incident myocardial infarction.

The researchers found that the 16,725 black patients were younger but had higher prevalence of obesity and hypertension (all P < 0.001). Black patients achieved a lower CRF on average than white patients (8.4 versus 9.5 metabolic equivalents; P < 0.0001). For both black and white patients, a graded increase in mortality risk was seen with decreasing CRF. In multivariate analysis, CRF predicted both myocardial infarction and mortality; there was no significant interaction for race, fitness, and outcomes (all interaction terms, P > 0.10).

"CRF is a strong predictor of all-cause mortality in both white and black patients, with no significant interaction observed between race, fitness, and outcomes," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »